Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab

Sofie Lieberoth; Simon Francis Thomsen

doi:10.1155/2015/903541

Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab

28 Citationer (Scopus)

Abstract

The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti-IgE) reduced gastrointestinal and cutaneous symptoms significantly. This observation provides additional insight into the effects of omalizumab on systemic mastocytosis.

Originalsprog	Engelsk
Tidsskrift	Case reports in medicine
Vol/bind	2015
Sider (fra-til)	903541
ISSN	1687-9627
DOI	https://doi.org/10.1155/2015/903541
Status	Udgivet - 2015

Adgang til dokumentet

10.1155/2015/903541

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{0ad7880fff0044f19f782c62d68a1290,

title = "Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab",

abstract = "The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti-IgE) reduced gastrointestinal and cutaneous symptoms significantly. This observation provides additional insight into the effects of omalizumab on systemic mastocytosis.",

author = "Sofie Lieberoth and Thomsen, \{Simon Francis\}",

year = "2015",

doi = "10.1155/2015/903541",

language = "English",

volume = "2015",

pages = "903541",

journal = "Case reports in medicine",

issn = "1687-9627",

publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab

AU - Lieberoth, Sofie

AU - Thomsen, Simon Francis

PY - 2015

Y1 - 2015

N2 - The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti-IgE) reduced gastrointestinal and cutaneous symptoms significantly. This observation provides additional insight into the effects of omalizumab on systemic mastocytosis.

AB - The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti-IgE) reduced gastrointestinal and cutaneous symptoms significantly. This observation provides additional insight into the effects of omalizumab on systemic mastocytosis.

UR - https://www.scopus.com/pages/publications/84952635511

U2 - 10.1155/2015/903541

DO - 10.1155/2015/903541

M3 - Journal article

C2 - 25694784

SN - 1687-9627

VL - 2015

SP - 903541

JO - Case reports in medicine

JF - Case reports in medicine

ER -

Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater